DYSLIPIDAEMIA
Clinical trials for DYSLIPIDAEMIA explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDAEMIA trials appear
Sign up with your email to follow new studies for DYSLIPIDAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could lower bad cholesterol, study underway
Disease control Recruiting nowThis study tests an experimental pill called AZD0780 for people with high cholesterol (dyslipidaemia). About 360 adults with elevated LDL-C will take the drug or a placebo for up to 52 weeks to see if it safely lowers cholesterol levels. The goal is to find a new treatment option…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2, PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
New cholesterol-lowering combo shows promise in mid-stage trial
Disease control Recruiting nowThis study tests whether adding a new drug (AZD0780) to a standard statin (rosuvastatin) can lower bad cholesterol more than the statin alone. About 76 adults with dyslipidaemia in Russia will take either the combination or a placebo plus statin for 12 weeks. The goal is to see i…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 06, 2026 16:02 UTC